LG
AZN icon

LAM Group’s AstraZeneca AZN Stock Holding History

LAM Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190 Hold
1
– – ﹤0.01% 135
2026
Q1 		$197 Buy
+1
New +$193 ﹤0.01% 131
2025
Q1 		– Sell
-1
Closed -$131 – 79
2024
Q4 		$131 Hold
1
– – ﹤0.01% 128
2024
Q3 		$156 Hold
1
– – ﹤0.01% 127
2024
Q2 		$156 Hold
1
– – ﹤0.01% 126
2024
Q1 		$136 Hold
1
– – ﹤0.01% 124
2023
Q4 		$135 Hold
1
– – ﹤0.01% 120
2023
Q3 		$135 Hold
1
– – ﹤0.01% 111
2023
Q2 		$143 Hold
1
– – ﹤0.01% 110
2023
Q1 		$139 Hold
1
– – ﹤0.01% 113
2022
Q4 		$136 Buy
+1
New +$125 ﹤0.01% 115

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

LAM Group's AZN Position: Q2 2026 in Review

LAM Group held its AstraZeneca (AZN) position steady in Q2 2026 at 1 share worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #135.

LAM Group first reported a position in AZN in Q4 2022 and has held it in 11 quarters since. The position peaked at $197 in Q1 2026. 620 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • LAM Group held 1 share of AstraZeneca worth $190 as of Q2 2026.
  • LAM Group left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of LAM Group's portfolio in Q2 2026, its #135 holding.
  • LAM Group first reported a position in AstraZeneca in Q4 2022 and has held it in 11 quarters since.
  • LAM Group's AstraZeneca position peaked at $197 in Q1 2026.
  • 620 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LAM Group's 13F filing for Q2 2026, filed 10 Jul 2026.